Ista Pharmaceuticals Inc Watch

from 10-Q 4 pages Fourth Amendment to Bromfenac License Agreement

from 10-K 1 page Executive Officers Party to an Executive Employment Agreement

from 10-K 12 pages Ista Pharmaceuticals, Inc. Executive Employee Agreement

from 10-K 16 pages Ista Pharmaceuticals, Inc. Executive Employee Agreement

from 10-K 3 pages First Amendment to Lease

from 8-K 62 pages Lease (Single Tenant; Net) Between the Irvine Company LLC and Ista Pharmaceuticals Index to Lease

from 8-K 2 pages Confidential Portions Have Been Omitted Based Upon a Request for Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and Have Been Separately Filed With the Securities and Exchange Commission Senju Pharmaceutical Co., Td. 2-5-8, Hiranomachi, Chuo-Ku, Osaka 541-0046, Japan Tel:+81-6-6201-9698 Fax:+81-6-6226-0406

from 8-K 1 page Yukoh Yoshida President Senju Pharmaceutical Co., Ltd. 5-8, Hiranomachi 2-Chome Chuo-Ku, Osaka, 541-0046 Japan Dear Mr. Yoshida: In Connection With Our Recent Letter Regarding Changing the Terms and Conditions of the Bromfenac License Agreement Dated March 7, 2002, and Amended August 13, 2002 and May 31, 2006, This Letter Is to Further Document Our Mutual Agreement to the Following Additional Change. Senju and Ista Agree That the Definition of Territory in the License Agreement Is Amended to Read: 1.02 “Territory” Shall Mean North America, Including the Possessions of the United States.” if You Agree to the Above, Please Sign and Date This and the Duplicate Copy of This Letter in the Space Provided Below and Return One Signed Copy to US. Sincerely Yours, /S/ Vicente Anido, Jr. Vicente Anido, Jr. President and CEO Ista Pharmaceuticals, Inc. Date: December 11, 2009 Agreed to and Accepted /S/ Yukoh Yoshida Yukoh Yoshida President Senju Pharmaceutical Co., Ltd

from 8-K 10 pages Fourth Amendment and Restatement of the Ista Pharmaceuticals, Inc. 2004 Performance Incentive Plan

from 8-K 6 pages Ista Pharmaceuticals, Inc. 2009 Employee Stock Purchase Plan

from 8-K 17 pages Security Agreement

from 8-K 12 pages Registration Rights Agreement

from 8-K 4 pages Amendment

from 8-K 34 pages Facility Agreement

from 10-K 1 page Executive Officers Party to an Executive Employment Agreement

from 10-K 1 page List of Indemnitees

from 10-Q 35 pages Confidential Portions Have Been Omitted Based Upon a Request for Confidential Treatment Pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and Have Been Separately Filed With the Securities and Exchange Commission. Exclusive License Agreement

from 8-K 12 pages Alton Plaza Fifth Amendment to Lease

from 8-K 34 pages Purchase Agreement Number of Shares to Be Purchased Price Per Share in Dollars Aggregate Price $ 7.00 $

from 8-K 15 pages Third Amendment and Restatement of the Ista Pharmaceuticals, Inc. 2004 Performance Incentive Plan